The appearance of nucleated red blood cells (NRBCs, erythroblasts) in the peripheral blood may be an early indicator of clinical deterioration in a critically-ill patients.
The appearance of NRBCs have been described in:
(1) ICU patients
(2) following cardiothoracic surgery
(3) with significant burn injury
NRBCs appear after several days of critical illness (1-2 weeks) and so tends to be a finding seen in patients who are more seriously ill. For patients who died they appeared about 1 week prior to death.
Implications:
(1) The appeareance of NRBCs may precede clinical deterioration.
(2) The in-hospital mortality is higher, especially if the number of NRBCs continues to increases.
(3) A critically-ill patient with NRBCs in the peripheral blood should be monitored closely and should not be transferred to a general ward.
Stachon et al (2004) reported that each increase in 1 absolute NRBC per µL (10^6/L) increased the odds ratio of in-hospital mortality by 1.01. Stachon (2006) reported
Absolute NRBC |
Odds Ratio for Mortality |
---|---|
0 |
1 |
1 to 40 per µL |
1.8 |
41 to 80 per µL |
3.2 |
81 to 240 per µL |
5.8 |
> 240 per µL |
10.5 |
Stachon et al (2007) correlated the absolute NRBC count with increases in the APACHE II score.
Absolute NRBC |
Increase to APACHE II |
---|---|
0 |
+0 |
1 to 100 per µL |
+4 |
101 to 200 per µL |
+8 |
> 200 per µL |
+12 |
Differential diagnosis: presence of NRBCs for another cause
Specialty: Hematology Oncology, Clinical Laboratory
ICD-10: ,